Growing Demand for CROS is a Key Trend Gaining Market Momentum
1h Free Analyst Time
The clinical trial supplies market is forecasted to grow by USD 1.31 billion during 2023-2028, accelerating at a CAGR of 8.65% during the forecast period. The report on the clinical trial supplies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth of biopharmaceutical industry, government initiatives on clinical research, and regulation of clinical trials in regional markets.
The clinical trial supplies market is segmented as below:
By End-user
- Pharmaceutical industry
- Biologics industry
- Medical device industry
By Type
- Phase III
- Phase II
- Phase IV and BE/BA studies
- Phase I
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the clinical trial supplies market covers the following areas:
- Clinical trial supplies market sizing
- Clinical trial supplies market forecast
- Clinical trial supplies market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global clinical trial supplies market: Ancillare LP, Avantor Inc., Bionical Emas Group, Bushu Pharmaceuticals Ltd., Catalent Inc., Clinical Services International Ltd., Clinigen Group Plc, Deutsche Bahn AG, Emsere B.V, GNH India Pharmaceuticals Ltd., International Bonded Couriers Inc., Nuvisan GmbH, Obvio Health USA Inc., Parexel International Corp., PCI Pharma Services, PHOENIX Pharmahandel GmbH and Co KG, Piramal Enterprises Ltd., Precision Medicine Group LLC, Thermo Fisher Scientific Inc., and Vertical Pharma Resources Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing demand for cros."
According to the report, one of the major drivers for this market is the growth of biopharmaceutical industry.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Ancillare LP
- Avantor Inc.
- Bionical Emas Group
- Bushu Pharmaceuticals Ltd.
- Catalent Inc.
- Clinical Services International Ltd.
- Clinigen Group Plc
- Deutsche Bahn AG
- Emsere B.V
- GNH India Pharmaceuticals Ltd.
- International Bonded Couriers Inc.
- Nuvisan GmbH
- Obvio Health USA Inc.
- Parexel International Corp.
- PCI Pharma Services
- PHOENIX Pharmahandel GmbH and Co KG
- Piramal Enterprises Ltd.
- Precision Medicine Group LLC
- Thermo Fisher Scientific Inc.
- Vertical Pharma Resources Ltd.
